WHO SMART Guidelines - HIV
0.4.3 - ci-build
WHO SMART Guidelines - HIV - Local Development build (v0.4.3) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Draft as of 2025-02-07 |
{
"resourceType" : "Library",
"id" : "HIVIND51Logic",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"🔗 ,
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"🔗 ,
"http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"🔗 ,
"http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<div>\n <table class=\"grid dict\">\n \n \n <tr>\n <th scope=\"row\"><b>Title: </b></th>\n <td style=\"padding-left: 4px;\">HIV.IND.51 Logic</td>\n </tr>\n \n\n \n \n <tr>\n <th scope=\"row\"><b>Id: </b></th>\n <td style=\"padding-left: 4px;\">HIVIND51Logic</td>\n </tr>\n \n\n \n \n <tr>\n <th scope=\"row\"><b>Version: </b></th>\n <td style=\"padding-left: 4px;\">0.4.3</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Url: </b></th>\n <td style=\"padding-left: 4px;\"><a href=\"Library-HIVIND51Logic.html\">HIV.IND.51 Logic</a></td>\n </tr>\n \n\n \n\n \n\n \n <tr>\n <th scope=\"row\"><b>Status: </b></th>\n <td style=\"padding-left: 4px;\">draft</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Experimental: </b></th>\n <td style=\"padding-left: 4px;\">true</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Type: </b></th>\n <td style=\"padding-left: 4px;\">\n \n \n \n <p style=\"margin-bottom: 5px;\">\n <b>system: </b> <span><a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-library-type.html\">http://terminology.hl7.org/CodeSystem/library-type</a></span>\n </p>\n \n \n <p style=\"margin-bottom: 5px;\">\n <b>code: </b> <span>logic-library</span>\n </p>\n \n \n \n \n \n </td>\n </tr>\n \n\n \n\n \n <tr>\n <th scope=\"row\"><b>Date: </b></th>\n <td style=\"padding-left: 4px;\">2025-02-07 14:15:45+0000</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Publisher: </b></th>\n <td style=\"padding-left: 4px;\">WHO</td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Description: </b></th>\n <td style=\"padding-left: 4px;\"><div><p>% of people living with HIV newly initiated on ART and tested for TB who are diagnosed with active TB disease</p>\n</div></td>\n </tr>\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n <tr>\n <td colspan=\"2\">\n <table>\n <tr><th><a id=\"cql-content\"><b>Content: </b></a> text/cql</th></tr>\n <tr><td><pre><code class=\"language-cql\">/**\n * Library: HIV.IND.51 Logic\n * Ref No: DFT.4\n * Short Name: TB diagnosis among those tested for TB\n *\n * Definition: % of people living with HIV newly initiated on ART and tested for TB who are diagnosed with active TB disease\n *\n * Numerator: Number of people living with HIV newly initiated on ART who were diagnosed as having active TB disease\n * Numerator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period AND "Date of TB diagnosis" in the reporting period\n * Numerator Exclusions: \n *\n * Denominator: Number of people living with HIV who newly initiated ART and screened positive for TB symptoms who had appropriate diagnostic testing during the reporting period*\n * Denominator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period\n * Denominator Exclusions: \n *\n * Disaggregations:\n * • Gender (female, male, other**) \n * •\u00a0Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–49, 50+ years)*** \n * •\u00a0Cities and other administrative regions of epidemiologic importance \n * \n * Note: This indicator is related to but distinct from indicator TB.4 Percentage of people living with HIV newly initiated on ART who have active TB disease.\n *\n * Disaggregation Elements: Gender | Age\n *\n * Numerator and Denominator Elements:\n * ART start date \n * ART start type \n * Date of TB diagnosis \n * HIV status \n * TB diagnostic test category \n * TB diagnostic test date \n * TB screening date \n * TB screening result\n *\n * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022\n * \n * Data Concepts:\n * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth\n * HIV.A.DE18: Gender* | Gender of the client*\n * HIV.A.DE19: Female | Client identifies as female\n * HIV.A.DE20: Male | Client identifies as male\n * HIV.A.DE21: Transgender male | Client identifies as transgender male\n * HIV.A.DE22: Transgender female | Client identifies as transgender female\n * HIV.A.DE23: Other | Additional category\n * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)\n * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.\n * HIV.B.DE116: HIV-positive | Client is HIV-positive\n * HIV.B.DE117: HIV-negative | Client is HIV-negative\n * HIV.B.DE118: Unknown | Client has unknown HIV status\n * HIV.D.DE39: ART start date | The date on which the client started or restarted ART\n * HIV.D.DE43: ART start type | Whether the client is ART naive or is restarting ART\n * HIV.D.DE44: First-time user of ART | Client is ART naive, having never taken ART to treat HIV before\n * HIV.D.DE45: Restarting ART | Client is restarting ART after stopping treatment for any reason\n * HIV.D.DE952: Date of TB diagnosis | The date when the diagnosis was established\n * HIV.D.DE986: TB screening result | Record the result of the tuberculosis (TB) screening\n * HIV.D.DE987: Screen positive for TB | Screening result was positive for tuberculosis (TB)\n * HIV.D.DE988: Screen negative for TB | Screening result was negative for tuberculosis (TB)\n * HIV.D.DE989: Inconclusive | Screening result was inconclusive for tuberculosis (TB)\n * HIV.D.DE990: TB screening date | Date the TB screening was conducted\n * HIV.D.DE992: TB diagnostic test category | The type of diagnostic test performed to detect tuberculosis (TB) disease\n * HIV.D.DE993: LF-LAM | Client tested for tuberculosis with a lateral flow urine lipoarabinomannan assay\n * HIV.D.DE994: mWRD test for TB | Client tested with a WHO-recommended molecular diagnostic test to detect Mycobacterium tuberculosis (MTB)\n * HIV.D.DE995: Microscopy - Sputum acid-fast bacilli (AFB) | Client tested for tuberculosis with a sputum acid-fast bacilli (AFB)\n * HIV.D.DE996: TB Culture | Client tested for tuberculosis (TB) with a culture\n * HIV.D.DE997: TB diagnostic test date | The date when TB diagnostic test was performed\n * HIV.SRV.DE6: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)\n *\n * Additional Context\n * - what it measures: This indicator measures the percentage of people living with HIV newly initiated on ART and, having screened positive for active TB disease, were evaluated and/or had appropriate TB diagnostic testing and were confirmed to have active TB disease.\n * - rationale: • Appropriate TB diagnostic testing based on national clinical/WHO guidelines is essential for people living with HIV who screen positive for TB. | • It is important to understand the cascade from ART enrolment to treatment of active TB disease; this indicator will highlight any obstacles between diagnostic testing and TB diagnosis. | •\u00a0This is the fourth of five "screening cascade" indicators considered priority for high burden TB/HIV settings.\n * - method: "Newly initiated" is defined as the number of people living with HIV who start ART in accordance with national treatment guidelines during the reporting period. | For the numerator: Programme records (for example, ART registers, EMRs) | For the denominator: Programme records (for example, ART registers, EMRs)\n * \n * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm\n */\n\nlibrary HIVIND51Logic\n\n// Included Libraries\nusing FHIR version '4.0.1'\n\ninclude HIVCommon version '0.0.1' called HIC\ninclude FHIRHelpers version '4.0.1'\n\ninclude WHOCommon called WCom\ninclude HIVElements called HE\ninclude HIVIndicatorElements called HIE\n\n// Indicator Definition\nparameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]\n\ncontext Patient\n/* Populations */\n\n/*\n *Initial Population\n */\n\ndefine "Initial Population":\n true\n\n/**\n * Numerator\n * \n * Definition: Number of people living with HIV newly initiated on ART who were diagnosed as having active TB disease\n * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period AND "Date of TB diagnosis" in the reporting period\n */\n\ndefine "Numerator":\n HIE."Has HIV-positive Status"\n and (start of First(HE."First-time user of ART").effective.toInterval() during "Measurement Period")\n //related the two since we want a positive observation from a specific diagnostic test.\n and exists(\n HE."TB diagnostic test category" P\n with HE."Screen positive for TB" O\n such that P.partOf.references(O)\n where P.performed.toInterval() during "Measurement Period"\n )\n and HIE."Date of TB diagnosis"\n\n\n/**\n * Denominator\n *\n * Definition: Number of people living with HIV who newly initiated ART and screened positive for TB symptoms who had appropriate diagnostic testing during the reporting period*\n * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period\n */\n\ndefine "Denominator":\n HIE."Has HIV-positive Status"\n and (start of First(HE."First-time user of ART").effective.toInterval() during "Measurement Period")\n //related the two since we want a positive observation from a specific diagnostic test.\n and exists(\n HE."TB diagnostic test category" P\n with HE."Screen positive for TB" O\n such that P.partOf.references(O)\n where P.performed.toInterval() during "Measurement Period"\n )\n \n\n/* end Populations */\n\n/*\n * Disaggregators\n */\n\ndefine "Administrative Gender Stratifier":\n\tHIE."By Administrative Gender Stratifier"\n\ndefine "Age Stratifier":\n\tHIE."By Age Stratifier 2"\n\ndefine "Geographic Region Stratifier":\n\tHIE."By Geographic Region Stratifier"\n\ndefine "Stratification":\n HIE."By Administrative Gender Stratifier".code \n + ':' + HIE."By Age Stratifier 2"\n+ ':' + HIE."By Geographic Region Stratifier"</code></pre></td></tr>\n </table>\n </td>\n </tr>\n \n \n \n </table>\n</div>\n</div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode" : "computable"
}
],
"url" : "http://smart.who.int/hiv/Library/HIVIND51Logic",
"version" : "0.4.3",
"name" : "HIVIND51Logic",
"title" : "HIV.IND.51 Logic",
"status" : "draft",
"experimental" : true,
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/library-type",
"code" : "logic-library"
}
]
},
"date" : "2025-02-07T14:15:45+00:00",
"publisher" : "WHO",
"contact" : [
{
"name" : "WHO",
"telecom" : [
{
"system" : "url",
"value" : "http://who.int"
}
]
}
],
"description" : "% of people living with HIV newly initiated on ART and tested for TB who are diagnosed with active TB disease",
"content" : [
{
"contentType" : "text/cql",
"data" : "/**
 * Library: HIV.IND.51 Logic
 * Ref No: DFT.4
 * Short Name: TB diagnosis among those tested for TB
 *
 * Definition: % of people living with HIV newly initiated on ART and tested for TB who are diagnosed with active TB disease
 *
 * Numerator: Number of people living with HIV newly initiated on ART who were diagnosed as having active TB disease
 * Numerator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period AND "Date of TB diagnosis" in the reporting period
 * Numerator Exclusions: 
 *
 * Denominator: Number of people living with HIV who newly initiated ART and screened positive for TB symptoms who had appropriate diagnostic testing during the reporting period*
 * Denominator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (female, male, other**) 
 *  • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–49, 50+ years)*** 
 *  • Cities and other administrative regions of epidemiologic importance 
 *   
 *  Note: This indicator is related to but distinct from indicator TB.4 Percentage of people living with HIV newly initiated on ART who have active TB disease.
 *
 * Disaggregation Elements: Gender | Age
 *
 * Numerator and Denominator Elements:
 * ART start date 
 *  ART start type 
 *  Date of TB diagnosis 
 *  HIV status 
 *  TB diagnostic test category 
 *  TB diagnostic test date 
 *  TB screening date 
 *  TB screening result
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.
 * HIV.B.DE116: HIV-positive | Client is HIV-positive
 * HIV.B.DE117: HIV-negative | Client is HIV-negative
 * HIV.B.DE118: Unknown | Client has unknown HIV status
 * HIV.D.DE39: ART start date | The date on which the client started or restarted ART
 * HIV.D.DE43: ART start type | Whether the client is ART naive or is restarting ART
 * HIV.D.DE44: First-time user of ART | Client is ART naive, having never taken ART to treat HIV before
 * HIV.D.DE45: Restarting ART | Client is restarting ART after stopping treatment for any reason
 * HIV.D.DE952: Date of TB diagnosis | The date when the diagnosis was established
 * HIV.D.DE986: TB screening result | Record the result of the tuberculosis (TB) screening
 * HIV.D.DE987: Screen positive for TB | Screening result was positive for tuberculosis (TB)
 * HIV.D.DE988: Screen negative for TB | Screening result was negative for tuberculosis (TB)
 * HIV.D.DE989: Inconclusive | Screening result was inconclusive for tuberculosis (TB)
 * HIV.D.DE990: TB screening date | Date the TB screening was conducted
 * HIV.D.DE992: TB diagnostic test category | The type of diagnostic test performed to detect tuberculosis (TB) disease
 * HIV.D.DE993: LF-LAM | Client tested for tuberculosis with a lateral flow urine lipoarabinomannan assay
 * HIV.D.DE994: mWRD test for TB | Client tested with a WHO-recommended molecular diagnostic test to detect Mycobacterium tuberculosis (MTB)
 * HIV.D.DE995: Microscopy - Sputum acid-fast bacilli (AFB) | Client tested for tuberculosis with a sputum acid-fast bacilli (AFB)
 * HIV.D.DE996: TB Culture | Client tested for tuberculosis (TB) with a culture
 * HIV.D.DE997: TB diagnostic test date | The date when TB diagnostic test was performed
 * HIV.SRV.DE6: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 *
 * Additional Context
 * - what it measures: This indicator measures the percentage of people living with HIV newly initiated on ART and, having screened positive for active TB disease, were evaluated and/or had appropriate TB diagnostic testing and were confirmed to have active TB disease.
 * - rationale: • Appropriate TB diagnostic testing based on national clinical/WHO guidelines is essential for people living with HIV who screen positive for TB. | • It is important to understand the cascade from ART enrolment to treatment of active TB disease; this indicator will highlight any obstacles between diagnostic testing and TB diagnosis. | • This is the fourth of five "screening cascade" indicators considered priority for high burden TB/HIV settings.
 * - method: "Newly initiated" is defined as the number of people living with HIV who start ART in accordance with national treatment guidelines during the reporting period. | For the numerator: Programme records (for example, ART registers, EMRs)  | For the denominator: Programme records (for example, ART registers, EMRs)
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND51Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'

include WHOCommon called WCom
include HIVElements called HE
include HIVIndicatorElements called HIE

// Indicator Definition
parameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define "Initial Population":
  true

/**
 * Numerator
 * 
 * Definition: Number of people living with HIV newly initiated on ART who were diagnosed as having active TB disease
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period AND "Date of TB diagnosis" in the reporting period
 */

define "Numerator":
  HIE."Has HIV-positive Status"
  and (start of First(HE."First-time user of ART").effective.toInterval() during "Measurement Period")
  //related the two since we want a positive observation from a specific diagnostic test.
  and exists(
    HE."TB diagnostic test category" P
    with HE."Screen positive for TB" O
      such that P.partOf.references(O)
    where P.performed.toInterval() during "Measurement Period"
  )
  and HIE."Date of TB diagnosis"


/**
 * Denominator
 *
 * Definition: Number of people living with HIV who newly initiated ART and screened positive for TB symptoms who had appropriate diagnostic testing during the reporting period*
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period
 */

define "Denominator":
  HIE."Has HIV-positive Status"
  and (start of First(HE."First-time user of ART").effective.toInterval() during "Measurement Period")
  //related the two since we want a positive observation from a specific diagnostic test.
  and exists(
    HE."TB diagnostic test category" P
    with HE."Screen positive for TB" O
      such that P.partOf.references(O)
    where P.performed.toInterval() during "Measurement Period"
  )
    

/* end Populations */

/*
 * Disaggregators
 */

define "Administrative Gender Stratifier":
	HIE."By Administrative Gender Stratifier"

define "Age Stratifier":
	HIE."By Age Stratifier 2"

define "Geographic Region Stratifier":
	HIE."By Geographic Region Stratifier"

define "Stratification":
 HIE."By Administrative Gender Stratifier".code 
  + ':' + HIE."By Age Stratifier 2"
+ ':' + HIE."By Geographic Region Stratifier""
}
]
}